MODRASTANE Drug Patent Profile
✉ Email this page to a colleague
When do Modrastane patents expire, and when can generic versions of Modrastane launch?
Modrastane is a drug marketed by Bioenvision and is included in one NDA.
The generic ingredient in MODRASTANE is trilostane. There are two drug master file entries for this compound. Additional details are available on the trilostane profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MODRASTANE?
- What are the global sales for MODRASTANE?
- What is Average Wholesale Price for MODRASTANE?
Summary for MODRASTANE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Patent Applications: | 5,227 |
| DailyMed Link: | MODRASTANE at DailyMed |
US Patents and Regulatory Information for MODRASTANE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioenvision | MODRASTANE | trilostane | CAPSULE;ORAL | 018719-002 | Dec 31, 1984 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bioenvision | MODRASTANE | trilostane | CAPSULE;ORAL | 018719-001 | Dec 31, 1984 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
